Trials / Completed
CompletedNCT04018209
Aquagenic Pruritus in Myeloproliferative Neoplasms
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 170 (actual)
- Sponsor
- University Hospital, Brest · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Description of the characteristics of aquagenic pruritus expressed by patients suffering from myeloproliferative neoplasms. Prospective work based on the distribution of a dedicated questionnaire.
Detailed description
Patients with myeloproliferative neoplasms identified and followed in French Hospitals. Patients could be followed for polycythemia vera or essential thrombocythemia or primary myelofibrosis. Distribution of the questionnaire to each patient with myeloproliferative neoplasm (treated or not) suffering from aquagenic pruritus. Analyse of each characteristic of the aquagenic pruritus by a statistician and publication at the end.
Conditions
Timeline
- Start date
- 2019-07-09
- Primary completion
- 2020-01-09
- Completion
- 2021-01-06
- First posted
- 2019-07-12
- Last updated
- 2024-11-01
Locations
11 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04018209. Inclusion in this directory is not an endorsement.